Search research articles
Contact Us
Filters
Showing results (171-180 of 272) with videos related to
Page
of 28
Sort By:
Cancer
|
December 1, 1986
Intermittent endocrine therapy for advanced prostate cancer
L H Klotz, H W Herr, M J Morse, et al.
The Prostate
|
January 1, 1982
Effects of estrogen administration on serum testosterone in Copenhagen rats
H B Grossman, E L Kleinert, H W Herr, et al.
The Journal of Urology
|
July 1, 1994
The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy
B E Davis, H W Herr, W R Fair, et al.
Cancer
|
March 15, 1984
Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer
H W Herr, E L Kleinert, N M Relyea, et al.
The Journal of Urology
|
April 1, 1992
Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup
H W Herr, D D Wartinger, W R Fair, et al.
Cancer
|
August 15, 1994
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors
A G Aprikian, H W Herr, D F Bajorin, et al.
Urologic Oncology
|
December 12, 2002
A comparison of hospital-based charges following partial and radical nephrectomy
J M McKiernan, B Teschendorf, J Katz, et al.
Urology
|
October 1, 1985
Consideration for treatment of upper urinary tract tumors with topical therapy
J L Huffman, M J Morse, H W Herr, et al.
European Urology
|
January 1, 1991
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors
H W Herr, G C Toner, N L Geller, et al.
The Journal of Urology
|
May 9, 2001
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer
S M Donat, D C Wei, M S McGuire, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 272) with videos related to
Sort By:
Page
of 28
Cancer
|
December 1, 1986
Intermittent endocrine therapy for advanced prostate cancer
L H Klotz, H W Herr, M J Morse, et al.
The Prostate
|
January 1, 1982
Effects of estrogen administration on serum testosterone in Copenhagen rats
H B Grossman, E L Kleinert, H W Herr, et al.
The Journal of Urology
|
July 1, 1994
The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy
B E Davis, H W Herr, W R Fair, et al.
Cancer
|
March 15, 1984
Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer
H W Herr, E L Kleinert, N M Relyea, et al.
The Journal of Urology
|
April 1, 1992
Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup
H W Herr, D D Wartinger, W R Fair, et al.
Cancer
|
August 15, 1994
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors
A G Aprikian, H W Herr, D F Bajorin, et al.
Urologic Oncology
|
December 12, 2002
A comparison of hospital-based charges following partial and radical nephrectomy
J M McKiernan, B Teschendorf, J Katz, et al.
Urology
|
October 1, 1985
Consideration for treatment of upper urinary tract tumors with topical therapy
J L Huffman, M J Morse, H W Herr, et al.
European Urology
|
January 1, 1991
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors
H W Herr, G C Toner, N L Geller, et al.
The Journal of Urology
|
May 9, 2001
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer
S M Donat, D C Wei, M S McGuire, et al.
Page
of 28